Vistin Pharma Shares Dip 1.36% as Market Consolidates Amid Diabetes API Growth
Vistin Pharma shares dip 1.36% as investors await Q1 earnings; stable market cap and metformin pipeline keep the company poised for diabetes market growth.
2 minutes to read